Insight Molecular Diagnostics Inc. IMDX
3.92
(0.03)
(0.76%)
as of 25 Sep
- Market cap
- $129.3M
- P/E
- 0.0×
Follow IMDX
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 488.68% | 20,228.75% | 229.65% | (23,500.97%) |
+8 more TTM periods Free account |
|
| (123.46%) | (94.93%) | (165.10%) | (106.02%) | ||
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | |
Return on Tangible Assets |
(303.54%) | (174.46%) | (519.57%) | (338.53%) | |
Average Days of Receivables |
41.96 | 29.40 | 101.53 | 21.39 | |
Free Cash Flow per Share |
(0.84) | (0.80) | (0.83) | (0.75) | |
Free Cash Flow |
(31.00) | (27.47) | (25.37) | (23.91) | |
Capital Expenditures |
(3.92) | (3.49) | (3.18) | (1.92) | |
Piotroski F-Score |
1.00 | 2.00 | 4.00 | 4.00 | |
| Other line items | |||||
Cash ROIC |
1,425.91% | (131.50%) | 127.04% | (215.06%) | |
Accounts Receivable Turnover |
4.74 | 1.05 | 2.96 | 18.85 | |
Accounts Payable Turnover |
0.55 | 0.49 | 0.84 | 2.08 | |
Inventory Turnover |
1.92 | 2.29 | 4.11 | 5.70 | |
Average Days of Payables |
791.33 | 613.40 | 528.49 | 192.24 | |
Days of Inventory on Hand |
87.55 | 145.09 | 92.65 | 85.74 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
1,146.47% | 919.91% | 392.11% | 280.05% | |
Selling, General and Administrative Expense of Revenue |
1,121.56% | 926.01% | 418.64% | 366.20% | |
Share Based Compensation of Revenue |
150.78% | 121.14% | 54.72% | 45.37% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.55 | 0.50 | 0.44 | 0.36 | |
Depreciation/Fixed assets |
0.41 | 0.26 | 0.34 | 0.53 | |
Capex/Depreciation |
(1.60) | (1.49) | (1.45) | (0.87) | |
Revenue per Share |
0.05 | 0.06 | 0.13 | 0.14 | |
Operating CF per Share |
(0.74) | (0.69) | (0.73) | (0.69) | |
Capex per Share |
(0.11) | (0.10) | (0.10) | (0.06) | |
Capex to Sales |
2.35 | 1.79 | 0.79 | 0.44 | |
Net Profit Margin |
(2,955.63%) | (2,454.64%) | (1,238.52%) | (1,374.72%) |
Columns are period end dates